131I-IPA and Concurrent XRT in Recurrent GBM
Clinical trial NCT03849105 · COMPLETED
Trial details
- NCT number
- NCT03849105
- Sponsor
- Telix Pharmaceuticals (Innovations) Pty Limited
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-09
- Primary completion
- 2022-07-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.